What Are the Potential Side Effects of This Triple Agonist The most commonly reported adverse effects in clinical studies are gastrointestinal, consistent with the GLP-1 receptor agonist class
2025 Jan 27;26(3):1098
Similarly, 12 weeks of aerobic and resistance training increased NAMPT levels in skeletal muscle
Organ Growth Concerns at High Doses Because IGF-1 acts on all tissue not just muscle megadosing for extended periods may promote organ tissue hypertrophy, including intestinal walls and heart tissue
Free Radic Biol Med 53:659668 Pokropivny V, Lohmus R, Hussainova I, Pokropivny A, Vlassov S (2007) Introduction to nanomaterials and nanotechnology
Read review Dihexa for Endometriosis Brain Fog The November 2025 Lancet O&G/WH 'overlooked symptom' commentary from Edinburgh EXPPECT, the April 2025 Horn FACT-Cog 1,239-patient survey (~80% perceived cognitive impairment), the March 2025 NICE TA1057 Ryeqo approval (first daily pill on NHS), the April 2024 NICE NG73 update, the April 2026 renewed Womens Health Strategy with 117 action points, the 2023 Greaves CNS-wide glial activation mouse model, the BDNF/TrkB central-sensitisation directionality paradox, and the ~1.5 million UK women affected